AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Nov 30, 2016
5262_dirs_2016-11-30_7a8e6499-9d70-45c6-9261-40a0bad8dce2.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6103Q
GlaxoSmithKline PLC
30 November 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr S Dingemans
b)
Position/status
Chief Financial Officer
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
The grant of options over Ordinary Shares pursuant to the Company's ShareSave Plan 2016.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £12.95 | 208 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-11-30
f)
Place of the transaction
London Stock Exchange (XLON)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr S A Hussain
b)
Position/status
President, Global Pharmaceuticals
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
The grant of options over Ordinary Shares pursuant to the Company's ShareSave Plan 2016.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £12.95 | 694 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-11-30
f)
Place of the transaction
London Stock Exchange (XLON)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr P C Thomson
b)
Position/status
SVP, Communications & Government Affairs
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
The grant of options over Ordinary Shares pursuant to the Company's ShareSave Plan 2016.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £12.95 | 277 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-11-30
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHQBLFXQFFEFBB
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'QoJKIBs4pYYk3YHoUIcOirN2VUCvkBY3RMYFWC1xl0psjp_WfcVgJQGlobTIGexWcw6QAz_7GEnij5Q-pp-oMZlCtLOvKFiwx7kXZ-sRDxM1:y0mJ-AUbenExZsW-1sNG7xQz3QyclGJci5ZrhAGFl7kp1NI7F3rOooa2QQsTcsrVbF-eJyyXsfqofNH1epBQz3m12M9vAVoWu1ZmBo_48JY1'}});//]]>